Treatment for novel coronavirus shows promise in early lab tests

(NIH/National Institute of Allergy and Infectious Diseases) National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells. These results suggest that the drug combination could be used to treat patients infected with the new coronavirus, but more research is needed to confirm this preliminary finding.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news